↓ Skip to main content

Dove Medical Press

Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer

Overview of attention for article published in Biologics: Targets & Therapy, August 2010
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
13 Mendeley
Title
Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer
Published in
Biologics: Targets & Therapy, August 2010
DOI 10.2147/btt.s7223
Pubmed ID
Authors

Jaclyn Flanigan, Hari Deshpande, Scott Gettinger

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Israel 1 8%
Unknown 12 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 31%
Student > Ph. D. Student 3 23%
Lecturer 1 8%
Student > Master 1 8%
Student > Bachelor 1 8%
Other 2 15%
Unknown 1 8%
Readers by discipline Count As %
Medicine and Dentistry 4 31%
Agricultural and Biological Sciences 3 23%
Biochemistry, Genetics and Molecular Biology 2 15%
Nursing and Health Professions 1 8%
Physics and Astronomy 1 8%
Other 1 8%
Unknown 1 8%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 July 2018.
All research outputs
#8,595,692
of 25,522,520 outputs
Outputs from Biologics: Targets & Therapy
#110
of 285 outputs
Outputs of similar age
#38,084
of 104,199 outputs
Outputs of similar age from Biologics: Targets & Therapy
#2
of 2 outputs
Altmetric has tracked 25,522,520 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 285 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 104,199 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.